RobertJosephDaviesMD

PubMed

• VX-322: A Novel Dual Receptor Tyrosine Kinase Inhibitor for the Treatment of Acute Myelogenous Leukemia.
  Heidary, D.K., Huang, G., Boucher, D., Ma, J., Forster, C., Grey, R., Xu, J., Arnost, M., Choquette, D., Chen, G., Zhou, J., Yao, Y., Ball, E.D., Namchuk, M., Davies, ...> ;J Med Chem. 2012 Jan 26
• Design, Synthesis, and Evaluation of a Novel Dual Fms-Like Tyrosine Kinase 3/Stem Cell Factor Receptor (FLT3/c-KIT) Inhibitor for the Treatment of Acute Myelogenous Le...
  Davies, R.J., Pierce, A.C., Forster, C., Grey, R., Xu, J., Arnost, M., Choquette, D., Galullo, V., Tian, S., Henkel, G., Chen, G., Heidary, D.K., Ma, J., Stuver-Moody,...> ;J Med Chem. 2011 Oct 27
• The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses.
  Shannon, B.A., Cohen, R.J., de Bruto, H., Davies, R.J.> ;J Urol. 2008 Oct
• Molecular dynamics simulations of Hydrogenobacter thermophilus cytochrome c552: comparisons of the wild-type protein, a b-type variant, and the apo state.
  Smith, L.J., Davies, R.J., van Gunsteren, W.F.> ;Proteins. 2006 Nov 15
• Total Synthesis of (+)-Himbacine and (+)-Himbeline.
  Chackalamannil, S., Davies, R.J., Wang, Y., Asberom, T., Doller, D., Wong, J., Leone, D., McPhail, A.T.> ;J Org Chem. 1999 Mar 19
• Join now to see all